Kavita Iyer

CAS Lead Scientist Life Sciences

Bio

Kavita Iyer graduated with a Bachelor of Pharmacy from the University of Mumbai. Subsequently she earned her PhD in Medicinal Chemistry from Virginia Commonwealth University, VCU. She further pursued a post-doctoral fellowship in the Department of Physiology and Biophysics at VCU where she was trained as a structural biologist and subsequently worked as a Research Scientist. While at CAS, Kavita has worked on a wide range of topics including immuno-oncology, CRISPR therapeutics, rare diseases, and nano biosensors in Life Sciences as well as covalent inhibitors and PROTACs in Medicinal Chemistry.

Emerging Science

Shifting climate, spreading insects: The rising burden of vector-borne diseases

Vector-borne diseases are spreading to new regions as climate change intensifies, and public health systems need more treatment options to limit the impacts.
|Article
Biotechnology

Could xenotransplantation solve organ transplant shortages?

With the advent of genetic editing technology, researchers are increasingly able to address immuno-compatibility issues, getting closer to making organs and tissues available for transplant from animal donors to human recipients.
|Article
Drug Discovery

PPI inhibitors show promise in cancer trials

Small molecule PPI inhibitors are on the brink of improving cancer treatments
|Article
Emerging Science

Co-occurring concepts reveal new research directions in immuno-oncology

Concept co-occurrence analysis shows the newest ideas in scientific discovery and drives innovation in immuno-oncology.
|Article
Drug Discovery

PROTACs revolutionize small molecule drugs

PROTACs are driving small molecule drug development to treat cancer, neurodegenerative diseases and more
|Article
Biotechnology

Webinar: Big data insights in the quest to cure cancer

Experts discuss emerging trends in immuno-oncology, data challenges, and opportunities ahead for cancer researchers.
|Webinar
Drug Discovery

Emerging trends in immunotherapy and cancer

Immuno-oncology has the potential to treat cancer without sacrificing the patient's wellbeing.
|Article